Experimental and theoretical advances in functional understanding of flavonoids as anti-tumor agents

Anti-Cancer Agents in Medicinal Chemistry

Volumn 13, Issue 2, 2013, Pages 307-332

  Babu, Bandarugattu V ^a   Konduru, Naveen K ^a   Nakanishi, Waro ^b   Hayashi, Satoko ^b   Ahmed, Naseem ^a   Mitrasinovic, Petar M ^b,c  

^a INDIAN INSTITUTE OF TECHNOLOGY ROORKEE   (India)

^b WAKAYAMA UNIVERSITY   (Japan)

^c Belgrade Institute of Science and Technology   (Serbia)

Author keywords

Action; Anthocyanin; Anti cancer agent; Anti tumor activity; Antioxidant; Cell line; Chalcone; Clinical data; Cytotoxic activity; Flavanol; Flavanone; Flavone; Flavonoid; Flavopiridol; Function; Isoflavone; Mechanism; Quercetin; SAR; Structure

Indexed keywords

3 HYDROXYFLAVONE; ANTHOCYANIN; ANTINEOPLASTIC AGENT; AURANTIIN; BAICALEIN; CATECHIN; CHALCONE DERIVATIVE; CISPLATIN; CYANIDIN 3 GLUCOSIDE; DAIDZEIN; DELPHINIDIN; EPICATECHIN; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVOPIRIDOL; GENISTEIN; ISOFLAVONE DERIVATIVE; LUTEOLIN; MALVIDIN CHLORIDE; PACLITAXEL; PROANTHOCYANIDIN DERIVATIVE; PRUNETIN; PYRIDINE DERIVATIVE; QUERCETIN; XANTHOHUMOL;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CANCER PREVENTION; CELL GROWTH; DRUG STRUCTURE; HUMAN; LUNG NON SMALL CELL CANCER; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PANCREAS CARCINOMA; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; DNA, NEOPLASM; FLAVONOIDS; HUMANS; MOLECULAR STRUCTURE; NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84876741573     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/1871520611313020017     Document Type: Review

References (163)

1. Harborne, J.B. The Flavonoids: Advances in Research Since 1986; Chapman & Hall: London, 1994.
2. Ross, J.A.; Kasum, C.M. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu. Rev. Nutr., 2002, 22, 19-34.
3. Grotewold, E. The Science of Flavonoids; Springer: New York, 2006.
4. Ahmed, N.; Dubuc, C.; Rousseau, J.; Benard, F.; van Lier, J.E. Synthesis, characterization, and estrogen receptor binding affinity of flavone-, indole-, and furan-estradiol conjugates. Bioorg. Med. Chem. Lett., 2007, 17, 3212-3216.
5. Chahar, M.K.; Sharma, N.; Dobhal, M.P.; Joshi, Y.C. Flavonoids: a versatile source of anticancer drugs. Phcog. Rev., 2011, 5, 1-12.
6. Sedlacek, H.H.; Czech, J.; Naik, R.; Kaur, G.; Worland, P.; Losiewicz, M.; Parker, B.; Carlson, B.; Smith, A.; Senderowicz, A.; Sausville, E. Flavopiridol (L86 8275; NSC 649890): a new kinase inhibitor for tumor therapy. Int. J. Oncol., 1996, 9, 1143-1168.
7. Senderowicz, A.M.; Headlee, D.; Stinson, S.F.; Lush, R.M.; Kalil, N.; Villalba, L.; Hill, K.; Steinberg, S.M.; Figg, W.D.; Tompkins, A.; Arbuck, S.G.; Sausville, E.A. Phase I trial of continuous infusion flavopiridol, a novel cyclin dependent kinase inhibitor, in patients with refractory neoplasms. J. Clin. Oncol., 1998, 16. 2986-2999.
8. Wright, J.; Blatner, G.L.; Cheson, B.D. Clinical trials of flavopiridol. Oncology, 1998, 12, 1018-1024.
9. Czech, J.; Hoffmann, D.; Naik, R.; Sedlacek, H-H. Antitumor activity of flavone L86-8275. Int. J. Oncol., 1995, 6, 31-36.
10. Carlson, B.A.; Dubay, M.M.; Sausville, E.A.; Brizuela, L.; Worland, P.J. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK)2 and CDK4 in human breast carcinoma cells. Cancer Res., 1996, 56, 2973-2978.
11. Drees, M.; Dengler, W.A.; Roth, T.; Labonte, H.; Mayo, J.; Malspeis, L.; Grever, M.; Sausville, E.A.; Fiebig, H.H. Flavopiridol (L86-8275): selective antitumor in vitro and activity in vivo for prostate carcinoma cells. Clin. Cancer Res., 1997, 3, 273-279.
12. Bible, K.C.; Bible, R.H., Jr.; Kottke, T.J.; Svingen, P.A.; Xu, K.; Pang, Y-P.; Hajdu, E.; Kaufmann, S.H. Flavopiridol binds to duplex DNA. Cancer Research, 2000, 60, 2419-2428.
13. Stintzing, F.C.; Stintzing, A.S.; Carle, R.; Frei, B.; Wrolstad, R.E. Color and antioxidant properties of cyanidin-based anthocyanin pigments. J. Agric. Food Chem., 2002, 50, 6172-6181.
14. Sivasankar, V.; Moorthi, A.; Kannan, D.S.; Devi, P.S. Anthocyanin, and its antioxidant properties in selected fruits. J. Pharm. Res., 2011, 4, 800-806.
15. Geetha, M.; Ponmozhi, P.; Saravanakumar, M.; Suganyadevi, P. Extraction of anthocyanin and analyzing its antioxidant properties from different onion (Allium cepa) varieties. Int. J. Res. Pharm. Sci., 2011, 2, 497-506.
16. Awika, J.M.; Rooney, L.W.; Waniska, R.D. Anthocyanins from black sorghum and their antioxidant properties. Food Chem., 2004, 90, 293-301.
17. Pasko, P.; Barton, H.; Zagrodzki, P.; Gorinstein, S.; Fołta, M.; Zachwieja, Z. Anthocyanins, total polyphenols and antioxidant activity in amaranth and quinoa seeds and sprouts during their growth. Food Chem., 2009, 115, 994-998.
18. Garzon, G.A.; Wrolstad, R.E. Major anthocyanins and antioxidant activity of nasturtium flowers (Tropaeolum majus). Food Chem., 2009, 114, 44-49.
19. Cerezo, A.B.; Cuevas, E.; Winterhalter, P.; Garcia-Parrilla, M.C.; Troncoso, A.M. Isolation, identification, and antioxidant activity of anthocyanin compounds in Camarosa strawberry. Food Chem., 2010, 123, 574-582.
20. Meiers, S.; Kemeny, M.; Weyand, U.; Gastpar, R.; von Angerer, E.; Marko, D. The anthocyanidins cyanidin and delphinidin are potent inhibitors of the epidermal growth-factor receptor. J. Agric. Food Chem., 2001, 49, 958-962.
21. Tsuda, T.; Watanabe, M.; Ohshima, K.; Norinobu, S.; Choi, S.W. Antioxidative activity of the anthocyanin pigments cyanidin 3-O-beta-D-glucoside and cyanidin. J. Agri. Food Chem., 1994, 42, 2407-2410.
22. Tsuda, T.; Shiga, K.; Ohshima, K.; Kawakishi, S.; Osawa, T. Inhibition of lipid peroxidation and the active oxygen radical scavenging effect of anthocyanin pigments isolated from phaseolus vulgaris L. Biochem. Pharmacol., 1996, 52, 1033-1039.
23. Koide, T.; Kamei, H.; Hashimoto, Y.; Kojima, T.; Hasegawa, M. Antitumor effect of anthocyanin fractions extracted from red soybeans and red beans in vitro and in vivo. Cancer Biother. Radiopharmcol., 1997, 12, 277-280.
24. Viguera, C.G.; Zafrilla, P.; Barberan, F.A.T. The use of acetone as an extraction solvent for anthocyanins from strawberry fruit. Phytochem. Anal., 1998, 9, 274-277. effects
25. Noda, Y.; Kaneyuki, T.; Igarashi, K.; Mori, A.; Packer, L.; Antioxidant activity of nasunin, an anthocyanin in eggplant. Res. Commun. Mol. Pathol. Pharmacol., 1998, 102, 175-187.
26. Tsuda, T.; Horio, F.; Kitoh, J.; Osawa, T. Protective of dietary cyanidin 3-O-beta-D-glucoside on liver Ischemia-reperfusion injury in rats. Arc. Biochem. Biophy., 1999, 368, 361-366.
27. Wang, C.J.; Wang, J.M.; Lin, W.L.; Chu, C.Y.; Chou, F.P.; Tseng, T.H. Protective effect of hibiscus anthocyanins against tert-butyl hydroperoxide-induced hepatic toxicity in rats. Food Chem. Toxicol., 2000, 38, 411-416.
28. Kong, J.M.; Chia, L.S.; Goh, N.K.; Chia, T.F.; Brouillard, R. Analysis and biological activities of anthocyanins. Phytochemistry, 2003, 64, 923-933.
29. Garzon, G.A.; Narvaez, C.E.; Riedl, K.M.; Schwartz, S.J. Chemical composition, anthocyanins, non-anthocyanin phenolics and antioxidant activity of wild bilberry (Vaccinium meridionale Swartz) from Colombia. Food Chem., 2010, 122, 980-986.
30. Azevedo, J.; Fernandes, I.; Faria, A.; Oliveira, J.; Fernandes, A.; de Freitas, V.; Mateus, N. Antioxidant properties of anthocyanidins, anthocyanidin-3-glucosides and respective portisins. Food Chem., 2010, 119, 518-523.
31. Zheng, J.; Ding, C.; Wang, L.; Li, G.; Shi, J.; Li, H.; Wang, H.; Suo, Y. Anthocyanins composition and antioxidant activity of wild Lycium ruthenicum Murr. from Qinghai-Tibet Plateau. Food Chem., 2011, 126, 859-865.
32. Degenhardt, A.; Knapp, H.; Winterhalter, P. Separation and purification of anthocyanins by high-speed countercurrent chromatography and screening for antioxidant activity. J. Agric. Food Chem., 2000, 48, 338-343.
33. Pliszka, B.; Ciolkowska, G.H.; Mieleszko, E.; Czaplicki, S. Stability and antioxidative properties of acylated anthocyanins in three cultivars of red cabbage (Brassica oleracea L. var.capitata L. f. rubra). J. Sci. Food Agric., 2009, 89, 1154-1158.
34. Musellk, J.; Alonso, M.G.; Lopez, M.P.M.; Zemlicka, M.; Gonzalo, J.C.R. Measurement of antioxidant activity of wine catechins, procyanidins, anthocyanins and pyranoanthocyanins. Int. J. Mol. Sci., 2007, 8, 797-809.
35. Anastasia, D.; Maya, M.; Christos, A.K.; Dimitra, H.L.; Panagiotis, K. Natural and synthetic 2′-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity. Bioorg. Med. Chem., 2009, 17, 8073-8085.
36. Bandgar, B.P.; Shrikant, S.G.; Ragini, G.B.; Gawande, N.M.; Chandrahasya, N.K. Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents. Bioorg. Med. Chem., 2009, 17, 8168-8173.
37. Bandgar, B.P.; Shrikant, S.G.; Ragini, G.B.; Totre, J.V.; Khobragade, C.N. Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents. Bioorg. Med. Chem., 2010, 18, 1364-1370.
38. Cristobal, L.M.; Jan, F.S.; Vadim, I.; Mark, M.; Balz, F.; Max, L.D.; Donald, R.B. Antioxidant and pro-oxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J. Agric. Food Chem., 2000, 48, 3876-3884.
39. Susanne, V.; Susanne, O.; Gabi, B.; Heilmann, J. Natural and non-natural prenylated chalcones: synthesis, cytotoxicity and anti-oxidative activity. Bioorg. Med. Chem., 2008, 16, 4286-4293.
40. Kamat, V.S.; Chuo, F.Y.; Kubo, I.; Nakanishi, K. Antimicrobial agents from an East African medicinal plant Erythrina abyssinica. Heterocycles, 1981, 15, 1163-1170.
41. Susanne, V.; Matej, B.; Guido, J.; Jorg, H. Synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacological effect. Eur. J. Med. Chem., 2010, 45, 2206-2213.
42. Susanne, V.; Susanne, O.; Gabi, B.; Heilmann, J. Natural and non-natural prenylated chalcones: synthesis, cytotoxicity and anti-oxidative activity. Bioorg. Med. Chem., 2008, 16, 4286-4293.
43. Susanne, V.; Jorg, H. Synthesis, cytotoxicity, and antioxidative activity of minor prenylated chalcones from Humulus lupulus. J. Nat. Prod., 2008, 71, 1237-1241.
44. Mohammed, R.A.; Sastry, V.G.; Bano, N. Antibacterial and antioxidant activities of some novel chalcone derivatives. J. Pharm. Res., 2011, 4, 2347-2349.
45. Bois, F.; Boumendjel, A.; Mariotte, A.M.; Conseil, G.; Di, P.A. Synthesis and biological activity of 4-alkoxy chalcones: potential hydrophobic modulators of P-glycoprotein-mediated multidrug resistance. Bioorg. Med. Chem., 1999, 7, 2691-2695.
46. Srinivas, K.K.; Erin, H.; Catherine, P.; Hallur, G.; Nancy, E.D.; Saeed, R.K. Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents. J. Med. Chem., 2003, 46, 2813-2815.
47. Aneta, M.; Catherine, P.; Geetha, A.; Nancy, E.D.; Peng, H.; Saeed, R.K. Anticancer activities of novel chalcone and bis-chalcone derivatives. Bioorg. Med. Chem., 2006, 14, 3491-3495.
48. Sogawa, S.; Nihro, Y.; Ueda, H.; Izumi, A.; Miki, T.; Matsumoto, H.; Satoh, T. 3,4-Dihydroxychalcones as potent 5-lipoxygenase and cyclo-oxygenase inhibitors. J. Med. Chem., 1993, 36, 3904-3909.
49. Chika, N.; Nobuhide, K.; Hideki, M.; Ezhuthachan, J.; In, H.K.; Kenneth, L.K.; Takeo, T.; Yoshio, T.; Hitoshi, H.; Toshio, S. Synthesis and biological activities of fluorinated chalcone derivatives. Bioorg. Med. Chem., 2002, 10, 699-706.
50. Jung, S.H.; Park, S.Y.; Kim, P.Y.; Lim, S.S. Synthesis and PPAR-y ligand-binding activity of the new series of 2'-hydroxychalcone and thiazolidinedione derivatives. Chem. Pharm. Bull, 2006, 54, 368-371.
51. Babasaheb, P.B.; Shrikant, S.G. Synthesis and biological screening of a combinatorial library of p-chlorovinyl-chalcones as anticancer, anti-inflammatory and antimicrobial agents. Bioorg. Med. Chem., 2010, 18, 2060-2065.
52. Anindra, S.; Bandana, C; Munna, P.G.; Jawed, A.S.; Rituraj, K.; Rama P.T. Synthesis and anti breast cancer activity of biphenyl based chalcones. Bioorg. Med. Chem., 2010, 18, 4711-4720.
53. Braulio, I.; Alexis, T.; Fabian, O.; Jairo, Q.; Rodrigo, A.; Manuel, N.; Adolfo, S.; Justo, C. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents. Bioorg. Med. Chem., 2010, 18, 4965-4974.
54. Bhagat, S.; Sharma, R.; Sawant, D.M.; Sharma, L.; Chakraborti, A.K. LiOHH2O as a novel dual activation catalyst for highly efficient and easy synthesis of 1,3-diaryl-2-propenones by Claisen-Schmidt condensation under mild conditions. J. Mol. Catal. A: Chem., 2006, 244, 20-24.
55. Dalip, K.N.; Maruthi, K.; Kanako, A.; Eriko, K.; Hiroshi, H.; Takeo, I. Synthesis and biological evaluation of indolyl chalcones as antitumor agents. Bioorg. Med. Chem. Lett, 2010, 20, 3916-3919.
56. Yi, X.; Zheng, Y.Y.; Peng, X.; Kenneth, F.B.; Yuka, N.; Kuo, H.L. Antitumor agents. part 202: novel 2'-amino chalcones: design, synthesis and biological evaluation. Bioorganic & Medicinal Chemistry Letters, 2000, 10, 699-701.
57. Boumendjel, A.; Boccard, J.; Carrupt, P.A.; Nicolle, E.; Blanc, M.; Geze, A.; Choisnard, L.; Wouessidjewe, D.; Matera, E.L.; Dumontet, C. Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship. J. Med. Chem., 2008, 51, 2307-2310.
58. Cabrera, M.; Simoens, M.; Falchi, G.; Lavaggi, M.L.; Piro, O.E.; Castellano, E.E.; Vidal, A.; Azqueta, A.; Monge, A.; Lopez, d.C.A.; Sagrera, G.; Seoane, G.; Cerecetto, H.; Gonzalez, M. Synthetic chalcones, flavanones, and flavones as antitumoral agents: biological evaluation and structure-activity relationships. Bioorg. Med. Chem., 2007, 15, 3356-3367.
59. Jose, C.A.; Manuela, V.; Edith, M.; Mirko, Z.; Miguel, Q.; Abraham, J.V.; Robert, H.G.; Gerald, B.H. Synthesis, cytotoxicity and anti-trypanosoma cruzi activity of new chalcones. J. Med. Chem., 2008, 51, 6230-6234.
60. Deka, N.; Hadjeri, M.; Lawson, M.A.; Beney, C; Mariotte, A.M.; Boumendjel, A. Acetylated dimethoxyaniline as a key intermediate for the synthesis of aminoflavones and quinolones. Heterocycles, 2002, 57, 123-128.
61. Ahcene, B.; Julien, B.; Pierre-Alain, C; Edwige, N.; Madeleine, B.; Annabelle, G.; Luc, C; Denis, W.; Eva-Laure, M.; Charles, D. Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship. J. Med. Chem., 2008, 51, 2307-2310.
62. Koneni, V.S.; Manoj, K.; Ram, K.M.; Ravi, S.; Gitika, B.; Khanna, A.K.; Shivika, R.; Rakesh, S. Synthesis and anti-inflammatory activity of novel biscoumarin-chalcone hybrids. Bioorg. Med. Chem. Lett., 2011, 21, 4480-4484.
63. Nobuwa, A.; Mai, M.; Emi, O.; Shinji, O. C. Geranylated Chalcones from the stems of Angelica keiskei with superoxide-acavenging activity. J. Nat. Prod., 2008, 71, 1308-1310.
64. Mario, J.S.; Seiji, A.; Satoshi, T.; Hui, Y.; Kurt, A.R.; Margaret, J.B.; Roberto, R.G.; Bernard, W.I.; Edward, J.K. Cytotoxic chalcones and antioxidants from the fruits of Syzygium samarangense (Wax Jambu). Food Chemistry, 2008, 107, 813-819.
65. Giuseppina, C; Luis, M.E.; Alessandra, B.; Nunziatina, D.T. Antioxidant chalcone glycosides and flavanones from Maclura (Chlorophora) tinctoria. J. Nat. Prod., 2003, 66, 1061-1064.
66. Liu, X.-H.; Liu, H.F.; Shen, X.; Song, B.A.; Bhadury, P.S.; Zhu, H.L.; Liu, J.X.; Qi, X.B. Synthesis and molecular docking studies of novel 2-chloro-pyridine derivatives containing flavone moieties as potential antitumor agents. Bioorg. Med. Chem. Lett, 2010, 20, 4163-4167.
67. Kim, S.H.; Kumar, C.N.; Kim, H.J.; Kim, D.H.; Cho, J.; Jin, C; Lee, Y.S. Glucose-containing flavones - their synthesis and antioxidant and neuroprotective activities. Bioorg. Med. Chem. Lett., 2009, 19, 6009-6013.
68. Akama, T.; Shida, Y.; Sugaya, T.; Ishida, H.; Gomi, K.; Kasai, M. Novel 5-aminoflavone derivatives as specific antitumor agents in breast cancer. J. Med. Chem., 1996, 39, 3461-3469.
69. Matsuda, H.; Wang, T.; Managi, H.; Yoshikawa, M. Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg. Med. Chem., 2003, 11, 5317-5323.
70. Park, Y.; Lee, S.; Woo, Y.; Lim, Y. Relationships between structure and anti-oxidative effects of hydroxy flavones. Bull. Korean Chem. Soc., 2009, 30, 1397-1400.
71. Hasan, S.M.; Alam, M.M.; Husain, A.; Khanna, S.; Akhtar, M.; Zaman, M.S. Synthesis of 6-aminomethyl derivatives of benzopyran-4-one with dual biological properties: anti-inflammatory-analgesic and antimicrobial. Eur. J. Med. Chem., 2009, 44, 4896-4903.
72. Theja, N.D.; Choudary, P.T.; Reddy, I.M.; Avsss, G. Reddy, U.K. A facial synthesis of flavone derivatives used as potent anti-inflammatory agents. Int. J. Pharm. Pharm. Sci., 2011, 3 (Suppl 2), 51-54.
73. Van Acker, F.A.A.; Hageman, J.A.; Haenen, G.R.M.M.; van der Vijgh, W.J.F.; Bast, A.; Menge, W.M.P.B. Synthesis of novel 3,7-substituted-2-(3',4'-dihydroxyphenyl)-flavones with improved antioxidant activity. J. Med. Chem., 2000, 43, 3752-3760.
74. Chen, I L.; Chen, J.Y.; Shieh, P.C.; Chen, J.J.; Lee, C.H.; Juang, S.H.; Wang, T. C. Synthesis and antiproliferative evaluation of amide-containing flavone and isoflavone derivatives. Bioorg. Med. Chem., 2008, 16, 7639-7645.
75. Wang, T.C.; Chen, I.L.; Lu, P.J.; Wong, C.H.; Liao, C.H.; Tsiaoa, K.C.; Chang, K.M.; Chene, Y.L.; Tzeng, C.C. Synthesis, antiproliferative, and antiplatelet activities of oxime-and methyloxime-containing flavone and isoflavone derivatives. Bioorg. Med. Chem., 2005, 13, 6045-6053.
76. Silva, M.M.; Santosa, M.R.; Carocoa, G.; Rochaa, R.; Justino, G.; Mira, L. Structure-antioxidant activity relationships of flavonoids: a re-examination. Free Radic. Res., 2002, 36, 1219-1227.
77. Neves, M.P.; Cidade, H.; Pinto, M.; Silva, A.M.S.; Gales, L.; Damas, A.M.; Lima, R.T.; Vasconcelos, M.H.; Nascimento, M.S.J. Prenylated derivatives of baicalein and 3,7-dihydroxyflavone: synthesis and study of their effects on tumor cell lines growth, cell cycle and apoptosis. Eur. J. Med. Chem., 2011, 46, 2562-2574.
78. Cotelle, N.; Bernier, J.L.; Catteau, J.P.; Pommery, J.; Wallet, J.C.; Gaydou, E.M. Antioxidant properties of hydroxy flavones. Free Radic. Biol. Med., 1996, 20, 35-43.
79. Cao, G.; Sofic, E.; Prior, R.L. Antioxidant and pro-oxidant behavior of flavonoids: structure-activity relationships. Free Radic. Biol. Med., 1997, 22, 749-760.
80. Lim, H.; Jin, J.H.; Park, H.; Kim, H.P. New synthetic anti-inflammatory chrysin analog, 5,7-dihydroxy-8-(pyridine-4yl)flavone. Eur. J. Pharmcol., 2011, 670, 617-622.
81. Erdman, J.W.Jr.; Balentine, D.; Arab, L.; Beecher, G.; Dwyer, J.T.; Folts, J.; Harnly, J.; Hollman, P.; Keen, C.L.; Mazza, G.; Messina, M.; Scalbert, A.; Vita, J.; Williamson, G.; Burrowes, J. Flavonoids and heart health: proceedings of the ILSI North America flavonoids workshop, May 31-June 1, 2005, Washington, DC. J. Nutr., 2007, 137, 718S-737S.
82. Jiang, Y.M.; Duan, X.W.; Joyce, D.; Zhang, Z.Q.; Li, J.R. Advances in understanding enzymatic browning of harvested litchi fruit. Food Chem., 2004, 88, 443-446.
83. Li, D.L.; Li, X.M.; Peng, Z.Y.; Wang, B.G. Flavanol derivatives from rhizophora stylosa and their DPPH radical scavenging activity. Molecules, 2007, 12, 1163-1169.
84. Zhao, M.; Yang, B.; Wang, J.; Li, B.; Jiang, Y. Identification of the major flavonoids from pericarp tissues of lychee fruit in relation to their antioxidant activities. Food Chem., 2006, 98, 539-544.
85. Monagas, M.; Garrido, I.; Aguilar, R.L.; Cordoves, M.C.G.; Rybarczyk, A.; Amarowicz, R.; Bartolome, B. Comparative flavan-3-ol profile and antioxidant capacity of roasted peanut, hazelnut, and almond skins. J. Agric. Food Chem., 2009, 57, 10590-10599.
86. Hwang, B.Y.; Kim, H.S.; Lee, J.H.; Hong, Y.S.; Ro, J.S.; Lee, K.S.; Lee, J.J. Antioxidant benzoylated flavan-3-ol glycoside from celastrus orbiculatus. J. Nat. Prod., 2001, 64, 82-84.
87. Tang, W.; Hioki, H.; Harada, K.; Kubo, M.; Fukuyama, Y. Antioxidant phenylpropanoid-substituted epicatechins from trichilia catigua. J. Nat. Prod., 2007, 70, 2010-2013.
88. Watanabe, M. Catechins as antioxidants from buckwheat (Fagopyrum esculentum Moench) groats. J. Agric. Food Chem., 1998, 46, 839-845.
89. Lozano, C.; Torres, J.L.; Julia, L.; Jimenez, A.; Centelles, J.J.; Cascante, M. Effect of new antioxidant cysteinyl-flavanol conjugates on skin cancer cells. FEBS Lett., 2005, 579, 4219-4225.
90. Omar, M.H.; Mullen, W.; Crozier, A. Identification of pro-anthocyanidin dimers and trimers, flavone C-glycosides, and antioxidants in ficus deltoidea, a malaysian herbal tea, J. Agric. Food Chem., 2011, 59, 1363-1369.
91. Tabkaa, A.C.; Murthi, K.K.; Kollol, P. Application of modified flavone closure for the preparation of racemic L86-8275. Ogr. Por. Res. Dev., 1999, 3, 256-259.
92. Lei, S.; Xiu, E.F.; Jing, R.C.; Lian, H.F.; Guan, H.D.; Qing, S.L. Synthesis and biological activity of flavanone derivatives. Bioorg. Med. Chem. Lett., 2010, 20, 5466-5468.
93. Hadi, P.; Shigeru, S.; Yoshiyuki, H.; Kimio, H. Efficient microwave-assisted prenylation of pinostrobin and biological evaluation of its derivatives as antitumor agents. Bioorg. Med. Chem. Lett., 2010, 20, 2086-2089.
94. Danila, D.M.; Marco, G.; Maurizio, L.G.; Elisa, T.; Santo, G.; Enrico, F. Flavanones in citrus fruit: structure-antioxidant activity relationships. Food Res. International, 2005, 38, 1161-1166.
95. Long, C.; Phuong, T.T.; Hyun, S.L.; Derek, T.N.; Joseph, T.M.; Zacharias, T.F.; Won, K.O. Flavanones from the stem bark of erythrina abyssinica. Bioorg. Med. Chem., 2008, 16, 10356-10362.
96. Magalhães, A.F.; Ruiz, A.L.T.G.; Tozzi, A.M.G.A.; Magalhães, E.G. Dihydroflavonols and flavanones from lonchocarpus atropurpureus roots. Phytochemistry, 1999, 52, 1681-1685.
97. Dagoberto, A.S.; Ricardo, R.C.; Manuel, J.E.; Federico, G.G.; Isabel, C.U.; Mario, S.S. Flavanones and 3-hydroxy flavanones from lonchocarpus oaxacensis. Phytochemistry, 2000, 55, 953-957.
98. Gomez, G.F.; Reyes, C.R.; Quijano, L.; Calderon, P.J.S.; Rõos, C.T. Methoxy furan auronols with fungistaticactivity from lonchocarpus castilloi. Phytochemistry, 1990, 29, 459-463.
99. Reyes, C.R.; Viveros, R.N.; Gomez, G.F.; Ala-vez, S.D. Antitermitic activity of Lonchocarpus castilloiflavonoids and heartwood extracts. J. Chem. Ecol., 1995, 21, 455-463.
100. Thanigaimalai, P.; Yang, H.M.; Sharma, V.K.; Kimb, Y.; Jung, S.H. The scope of thallium nitrate oxidative cyclization of chalcones; synthesis and evaluation of isoflavone and aurone analogs for their inhibitory activity against interleukin-5. Bioorg. Med. Chem., 2010, 18, 4441-4445.
101. Yang, H.M.; Shin, H.R.; Bang, S.C.; Lee, K.C.; Hoang, L.T.A.; Lee, I.J.; Kim, Y.; Jung, S.H. The role of alkoxy group on the ring of isoflavones in the inhibition of interleukin-5. Arch. Pharm. Res., 2007, 30, 950-954.
102. Ikedo, A.; Hayakawa, I.; Usui, T.; Kazami, S.; Osada, H.; Kigoshi, H. Structure-activity relationship study of glaziovianin A against cell cycle progression and spindle formation of HeLa S3 cells. Bioorg. Med. Chem. Lett., 2010, 20, 5402-5404.
103. Dowling, S.; Regan, F.; Hughes, H. The characterization of structural and antioxidant properties of isoflavone metal chelates. J. Inorg. Biochem., 2010, 104, 1091-1098.
104. Rimbach, G.; Teresa, S.D.P.; Ewins, B.A.; Matsugo, S.; Uchida, M.A.M.; Turner, R.; Vafeiadou, K.; Weinberg, P.D. Antioxidant and free radical scavenging activity of isoflavone metabolites. Xenobiotica, 2003, 33, 913-925.
105. Rufer, C.E.; Kulling, S.E. Antioxidant activity of isoflavones and their major metabolites using different in vitro assays. J. Agric. Food Chem., 2006, 54, 2926-2931.
106. Manthey, J.A.; Guthrie, N.; Grohmann, K. Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr. Med. Chem., 2001, 8, 135-153.
107. Surh, Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer, 2003, 3, 768-780.
108. Middleton, E.J.; Kandaswami, C.; Theoharides, T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol. Rev., 2000, 52, 673-751.
109. Galati, G.; Teng, S.; Moridani, M.Y.; Chan, T.S., Obrien P.J. Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics. Drug Metabol. Drug Interact., 2000, 17, 311-349.
110. Yang, C.S.; Landau, J.M.; Huang, M.T.; Newmark, H.L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu. Rev. Nutr., 2001, 21, 381-406.
111. Marchand, L.L.; Murphy, S.P.; Hankin, J.H.; Wilkens, L.R.; Kolonel, L.N. Intake of flavonoids and lung cancer. J. Natl. Cancer Inst., 2000, 92, 154-160.
112. Tsyrlov, I.B.; Mikhailenko, V.M.; Gelboin, H.V. Isozyme-and species-specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoids. Biochim. Biophys. Acta, 1994, 1205, 325-335.
113. Bu-Abbas, A.; Clifford, M.N.; Walker, R.; Ioannides, C. Contribution of caffeine and flavanols in the induction of hepatic phase II activities by green tea. Food Chem. Toxicol., 1998, 36, 617-621.
114. Sun, X.Y.; Plouzek, C.A.; Henry, J.P.; Wang, T.T.; Phang, J.M. Increased UDP-glucuronosyl transferase activity and decreased prostate specific antigen production by biochanin A in prostate cancer cells. Cancer Res., 1998, 58, 2379-2384.
115. The FRS Company. Clinical Studies on Benefits of Quercetin, Catechins, and other Flavonoids Found in FRS. http://ebookbrowse.com/clinical-data-on-quercetin-and-flavonoids-pdf-d104998660 http:// ebookbrowse.com/clinical-data-on-quercetin-and-flavonoids-pdf-d104998660(Accessed April 22, 2012).
116. Zheng, W.; Doyle, T.J.; Kushi, L.H.; Sellers, T.A.; Hong, C.-P.; Folsom, A.R. Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am. J. Epidemiol., 1996, 144, 175-182.
117. Zheng, W.; Sellers, T.A.; Doyle, T.J.; Kushi, L.H.; Potter, J.D.; Folsom, A.R. Retinol, antioxidant vitamins, and cancers of the upper digestive tract in a prospective cohort study of postmenopausal women. Am. J. Epidemiol., 1995, 142, 955-960.
118. Lee, L.T.; Huang, Y.T.; Hwang, J.J.; Lee, P.P. Ke, F.C.; Nair, M.P.; Kanadaswam, C.; Lee, M.T. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res., 2002, 22, 1615-1627.
119. Steinmetz, K.A.; Potter, J.D. Vegetables, fruit, and cancer prevention: a review. Journal of the American Dietetic Association, 1996, 96, 1027-1039.
120. Ferrandina, G.; Scambia, G.; Panici, P.B.; Ranelletti, F.O.; De Vincenzo, R.; Piantelli, M.; Distefano, M.; Capelli, A.; Mancuso, S. Type II estrogen-binding sites in human ovarian cancer: correlation with estrogen, progesterone, and epidermal growth factor receptor. Gynecologic Oncology, 1993, 49, 67-72.
121. De Stefani, E.; Ronco, A.; Mendilaharsu, M.; Deneo-Pellegrini, H. Diet and risk of cancer of the upper aerodigestive tract - II. nutrients. Oral Oncology, 1999, 35, 22-26.
122. Sabitha, K.E.; Shyamaladevi, C.S. Oxidant and antioxidant activity changes in patients with oral cancer and treated with radiotherapy. Oral Oncology, 1999, 35, 273-277.
123. Delanian, S.; Lefaix, J. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiotherapy and Oncology, 2004, 73, 119-131.
124. Schwarz, D.; Kisselev, P.; Roots, I. CYP1A1 genotype-selective inhibition of benzo[a]pyrene activation by quercetin. European Journal of Cancer, 2005, 41, 151-158.
125. Hirpara, K.V.; Aggarwal, P.; Mukherjee, A.J.; Joshi, N.; Burman, A.C. Quercetin and its derivatives: synthesis, pharmacological uses with special emphasis on anti-tumor properties and prodrug with enhanced bio-availability. Anti-Cancer Agents in Medicinal Chemistry, 2009, 9, 138-161.
126. Cummings, J.; Smyth, J.F. Flavone 8-acetic acid: our current understanding of its mechanism of action in solid tumours. Cancer Chemother. Pharmacol., 1989, 24, 269-272.
127. McKeage, M.J.; Kestell, P.; Denny, W.A.; Baguley, B.C. Plasma pharmacokinetics of the antitumour agents 5,6-dimethylxanthenone-4-acetic acid, xanthenone-4-acetic acid and flavone-8-acetic acid in mice. Cancer Chemother. Pharmacol., 1991, 28, 409-413.
128. Ching, L.M.; Joseph, W.R.; Baguley, B.C. Stimulation of macrophage tumouricidal activity by 5,6-dimethyl-xanthenone-4-acetic acid, a potent analogue of the antitumour agent flavone-8-acetic acid. Biochem. Pharmacol., 1992, 44, 192-195.
129. Jassar, A.S.; Suzuki, E.; Kapoor, V.; Sun, J.; Silverberg, M.B.; Cheung, L. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6- dimethylxan -thenone-4-acetic acid induces an effective CD8 + T-cell mediated antitumor immune response in murine models of lung cancer and mesothelioma. Cancer Res., 2005, 65, 11752-11761.
130. Phillips, R.M. Inhibition of DT-diaphorase (NAD (P) H: quinine oxidoreductase, EC 1.6.99.2) by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and flavone-8-acetic acid (FAA): implications for bioreductive drug development. Biochem. Pharmacol., 1999, 58, 303-310.
131. Baguley, B.C.; Cole, G.; Thomsen, L.L.; Li, Z. Serotonin involvement in the antitumour and Host effects of flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid. Cancer Chemother. Pharmacol., 1993, 33, 77-81.
132. Kelland, L.R. Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status. Expert Opin. Investig. Drugs., 2000, 9, 2903-2911.
133. Hollingsworth, R.E., Jr.; Hensey, C.E.; Lee, W.H. Retinoblastoma protein and the cell cycle. Curr. Opin. Genet. Dev., 1993, 3, 55-62.
134. Boege, F.; Straub, T.; Kehr, A.; Boesenberg, C.; Christiansen, K.; Andersen, A.; Jakob, F.; Kohrle, J. Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I. J. Biol. Chem., 1996, 271, 2262-2270.
135. Cos, P.; Ying, L.; Calomme, M.; Hu, J.P.; Cimanga, K.; Van Poel, B. Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J. Natural Products, 1998, 61, 71-76.
136. Rice-Evans, C.A.; Miller, N.J.; Paganga, G. Structure antioxidant-activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med., 1996, 20, 933-956.
137. Cao, G.; Sofic, E.; Prior, R.L. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic. Biol. Med., 1997, 22, 749-760.
138. Pannala, A.S.; Chan, T.S.; O'Brien, P.J.; Rice-Evans, C.A. Flavonoid B-ring chemistry and antioxidant activity: fast reaction kinetics. Biochem. Biophys. Res. Commun., 2001, 282, 1161-1168.
139. Burda, S.; Oleszek, W. Antioxidant and antiradical activities of flavonoids. J. Agric. Food Chem., 2001, 49, 2774-2779.
140. Haenen, G.R.; Paquay, J.B.; Korthouwer, R.E.; Bast, A. Peroxynitrite scavenging by flavonoids. Biochem. Biophys. Res. Commun., 1997, 236, 591-593.
141. Aparicio, S. A systematic computational study on flavonoids. Int. J. Mol. Sci., 2010, 11, 2017-2038.
142. Kanakis, C.D.; Nafisi, Sh.; Rajabi, M.; Shadaloi, A.; Tarantilis, P.A.; Polissiou, M.G.; Bariyanga, J.; Tajmir-Riahi, H.A. Structural analysis of DNA and RNA interactions with antioxidant flavonoids. Spectroscopy, 2009, 23, 29-43.
143. Sun, H.; Tang, Y.; Xiang, J.; Xu, G.; Zhang, Y.; Zhang, H.; Xu, L. Spectroscopic studies of the interaction between quercetin and G-quadruplex DNA. Bioorg. Med. Chem. Lett., 2006, 16, 3586-3589.
144. Sun, H.; Xiang, J.; Tang, Y.; Xu, G. Regulation and recognization of the extended G-quadruplex by rutin. Biochem. Biophys. Res. Commun., 2007, 352, 942-946.
145. Hussain, S.T.; Siddiqa, A. Voltammetric and viscometric studies of flavonoids interactions with DNA at physiological conditions. European Journal of Chemistry, 2011, 2, 109-112.
146. Bible, K.C.; Kaufmann, S.H. Flavopiridol (NSC 649890, L86-8275): a cytotoxic flavone that induces cell death in human lung carcinoma cells. Cancer Res., 1996, 56, 4856-4861.
147. Adjei, A.A.; Charron, M.; Rowinsky, E.K.; Svingen, P.A.; Miller, J.; Reid, J.C.; Sebolt-Leopold, J.; Ames, M.M.; Kaufmann, S.H. Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II: prevention of cleavable complex formation. Clin. Cancer Res., 1998, 4, 683-691.
148. Sebolt, J.S.; Scavone, S.V.; Pinter, C.D.; Hemelehle, K.L.; Von Hoff, D.D.; Jackson, R.C. Pyrazoloacridine, a new class of antitumor agents with selectivity against solid tumors in vitro. Cancer Res., 1987, 47, 4299-4304.
149. Usha, S.; Johnson, M.I.; Malathi, R. Interaction of resveratrol and genistein with nucleic acids. J. Biochem. Mol. Biol., 2005, 38, 198-205.
150. Pavlov, A.; Mitrasinovic, P.M. Theoretical insights into dispersion and hydrogen-bonding interactions in biomolecular systems. Current Organic Chemistry, 2010, 14, 129-138.
151. Mendoza-Wilson, A.M.; Glossman-Mitnik, D. CHIH-DFT study of the electronic properties and chemical reactivity of quercetin. Journal of Molecular Structure: THEOCHEM, 2005, 716, 67-72.
152. Ragazzon, P.A.; Bradshaw, T.; Matthews, C.; Iley, J.; Missailidis, S. The characterisation of flavone-DNA isoform interactions as a basis for anti-cancer drug development. Anticancer Research, 2009, 29, 2273-2283.
153. Ragazzon, P.A.; Iley, J.; Missailidis, S. Structure-activity studies of the binding of the flavonoid scaffold to DNA. Anticancer Research, 2009, 29, 2285-2293.
154. Dhaouadi, Z.; Nsangou, M.; Garrab, N.; Anouar, E.H.; Marakchi, K.; Lahmar, S. DFT study of the reaction of quercetin with ·O2 and ·OH radicals. Journal of Molecular Structure: THEOCHEM, 2009, 904, 35-42.
155. Trouillas, P.; Marsal, P.; Siri, D.; Lazzaroni, R.; Duroux J-L. A DFT study of the reactivity of OH groups in quercetin and taxifolin antioxidants: the specificity of the 3-OH site. Food Chemistry, 2006, 97, 679-688.
156. Murata, M.; Midorikawa, K.; Koh, M.; Umezawa, K.; Kawanishi, S. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs. Biochemistry, 2004, 43, 2569-2577.
157. Fan, P.M.; Wang, B. Preparation of quercetin's metal-complexing imprinted polymer membrane and its properties. Acta Chimica Sinica, 2010, 68, 2543-2550.
158. Shan, J.J.; Wang, B. Preparation and characterization of a metal-complexing imprinted polymer for improved quercetin recognition. Separation Science and Technology, 2011, 46, 164-171.
159. Peer, W.A.; Murphy, A.S. Flavonoids as signal molecules: targets of flavonoids action. The Science of Flavonoids, 2006, 239-268.
160. J.P.E. Flavonoids: modulators of brain function? British Journal of Nutrition, 2008, 99, ES60-ES77.
161. Yamashita, N.; Tanemura, H.; Kawanishi, S. Mechanism of oxidative DNA damage induced by quercetin in the presence of Cu(II). Mutat. Res., 1999, 425, 107-115.
162. Shan, J.J.; Wang, B. Preparation of quercetin-Cu(II) complex molecularly imprinted polymer and its binding characteristics. Acta Polymerica Sinica, 2011, 0, 100-106.
163. Bukhari, S.B.; Memon, S.; Mahroof-Tahir, M.; Bhanger, M.I. Synthesis, characterization and antioxidant activity of copper-quercetin complex. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2008, 1878398-1878398.